Key Points
- Director Robin Shane Readnour sold 35,402 Anthem shares at an average price of $6.01, generating approximately $212,766. Following the sale, Readnour retained 565,592 shares, a 5.89% reduction in ownership.
- Anthem shares opened at $5.96, with a market capitalization of approximately $224.9 million, and reported a quarterly loss of $0.18 per share. The stock has traded between $1.00 and $7.19 over the past year.
- Analyst sentiment is mixed, with an average rating of “Hold” and a $9.00 price target; institutional investors own 90.47% of the company.
-logo-1200x675.jpg?v=20220419083428)
Anthem, Inc. (NASDAQ:ANTX - Get Free Report) Director Robin Shane Readnour sold 35,402 shares of Anthem stock in a transaction on Monday, August 17th. The stock was sold at an average price of $6.01, for a total transaction of $212,766.02. Following the completion of the transaction, the director directly owned 565,592 shares of the company's stock, valued at $3,399,207.92. The trade was a 5.89% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink.
Anthem Trading Down 0.2%
Shares of NASDAQ ANTX opened at $5.96 on Thursday. The firm's 50-day moving average price is $5.11 and its 200-day moving average price is $3.95. The stock has a market capitalization of $224.93 million, a price-to-earnings ratio of -5.57 and a beta of -0.99. Anthem, Inc. has a 12-month low of $1.00 and a 12-month high of $7.19.
Anthem (NASDAQ:ANTX - Get Free Report) last released its quarterly earnings results on Tuesday, August 11th. The company reported ($0.18) EPS for the quarter.
Wall Street Analyst Weigh In
ANTX has been the topic of several recent analyst reports. Guggenheim initiated coverage on shares of Anthem in a research note on Monday, July 20th. They issued a "buy" rating and a $9.00 target price on the stock. Wall Street Zen raised Anthem from a "sell" rating to a "hold" rating in a research note on Sunday, June 14th. Weiss Ratings reiterated a "sell (d-)" rating on shares of Anthem in a report on Monday, July 6th. Finally, Leerink Partners raised Anthem from a "market perform" rating to an "outperform" rating and set a $9.00 price target for the company in a research note on Thursday, May 14th. Two equities research analysts have rated the stock with a Buy rating and one has issued a Sell rating to the stock. Based on data from MarketBeat.com, the stock presently has an average rating of "Hold" and an average price target of $9.00.
Check Out Our Latest Stock Report on ANTX
Institutional Trading of Anthem
Several institutional investors and hedge funds have recently modified their holdings of ANTX. ADAR1 Capital Management LLC bought a new position in Anthem in the first quarter worth approximately $47,000. OMERS ADMINISTRATION Corp bought a new stake in Anthem during the 1st quarter valued at $54,000. Seven Fleet Capital Management LP bought a new stake in Anthem during the 1st quarter valued at $683,000. Bank of America Corp DE grew its position in shares of Anthem by 2.2% during the 1st quarter. Bank of America Corp DE now owns 393,702 shares of the company's stock worth $1,346,000 after buying an additional 8,390 shares in the last quarter. Finally, Citizens Financial Group Inc. RI bought a new position in shares of Anthem during the 2nd quarter worth $1,443,000. Institutional investors own 90.47% of the company's stock.
About Anthem
(
Get Free Report)
Anthem, Inc, through its subsidiaries, operates as a health benefits company in the United States. It operates through three segments: Commercial & Specialty Business, Government Business, and Other. The company offers a spectrum of network-based managed care health benefit plans to large and small group, individual, Medicaid, and Medicare markets. Its managed care plans include preferred provider organizations; health maintenance organizations; point-of-service plans; traditional indemnity plans and other hybrid plans, such as consumer-driven health plans; and hospital only and limited benefit products.
See Also
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
